ImmunCR Id : | ICR46 |
Chemical Name : | Β-Carotene |
Plant Source : | Actinidia deliciosa |
Nutraceutical information : | Edible, carrot, pumpkin, spinach, tomatoe, watermelon and raspberries, cow milk |
Mode of administration : | Oral |
Immunomodulatory mechanism : | Obesity (production of interleukin (IL)-1β, IL-6, and tumor necrosis factor-alpha (TNF-α), modulating the physiology of adipocytes by producing β-apo-14′-carotenal, regulate lipogenesis through suppression of the peroxisome-proliferator-activated receptor (PPAR)-y); Type 2 Diabetes Mellitus (insulin resistance induced by DEHP (di-2-ethylhexyl phthalate)); Anti-inflammatory ( inhibits NF-κb and reduced IL-1β, IL-18, attenuated TNF-α); Antioxidant (ROS scavenging); secretion of immunomodulatory lipid molecules like leukotrienes and prostaglandins; Supports accumulation of platelets that is responsible for reconstruction of blood vessels, |
Description : | Β-Carotene a polyene compound belonging to the unoxidzed group of carotenoids with eight isoprene units and two β-ionone-ring at either ends. It is a secondary metabolite originating from acyclic structure and conjugated double bond along the long chain revealing its bright red-orange color. It is used as an additive in pharmaceutical industry for coloring the tablets and also for medicinal purpose due to its high bioactivity. |
IUPAC Name | 1,3,3-trimethyl-2-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohexene |
SMILES | CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C)C)C |
Formula | C40H56 |
InchiKey | OENHQHLEOONYIE-UHFFFAOYSA-N |
Kingdom | Organic compounds |
Superclass | Lipids and lipid-like molecules |
Class | Prenol lipids |
Subclass | Tetraterpenoids |
LogP | 11.998 |
Molecular weight | 536.873 |
Hydrogen Bond Acceptor | 0 |
Hydrogen Bond Donor | 0 |
Polar surface area | 0 |
No. of rotatable bonds | 10 |
Number of Aromatic Rings | 0 |
Number of rings | 2 |
Absorption level | Very low |
Solubility level | Very Soluble |
Blood Brain Barrier | Undefined |
Plasma protein binding | Binder |
CYP2D6 inhibition | Inhibitor |